- Home
- SNTI vs TLYS Comparison
SNTI vs TLYS Comparison
Compare SNTI & TLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- TLYS
- Stock Information
- Founded
- SNTI 2016
- TLYS 1982
- Country
- SNTI United States
- TLYS United States
- Employees
- SNTI N/A
- TLYS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- TLYS Clothing/Shoe/Accessory Stores
- Sector
- SNTI Health Care
- TLYS Consumer Discretionary
- Exchange
- SNTI Nasdaq
- TLYS Nasdaq
- Market Cap
- SNTI 53.6M
- TLYS 44.0M
- IPO Year
- SNTI N/A
- TLYS 2012
- Fundamental
- Price
- SNTI $1.91
- TLYS $1.49
- Analyst Decision
- SNTI Strong Buy
- TLYS Hold
- Analyst Count
- SNTI 3
- TLYS 2
- Target Price
- SNTI $9.67
- TLYS $2.25
- AVG Volume (30 Days)
- SNTI 292.3K
- TLYS 95.3K
- Earning Date
- SNTI 11-12-2025
- TLYS 12-04-2025
- Dividend Yield
- SNTI N/A
- TLYS N/A
- EPS Growth
- SNTI N/A
- TLYS N/A
- EPS
- SNTI N/A
- TLYS N/A
- Revenue
- SNTI N/A
- TLYS $549,597,000.00
- Revenue This Year
- SNTI N/A
- TLYS N/A
- Revenue Next Year
- SNTI $150.00
- TLYS $1.18
- P/E Ratio
- SNTI N/A
- TLYS N/A
- Revenue Growth
- SNTI N/A
- TLYS N/A
- 52 Week Low
- SNTI $1.26
- TLYS $0.57
- 52 Week High
- SNTI $16.94
- TLYS $4.77
- Technical
- Relative Strength Index (RSI)
- SNTI 49.03
- TLYS 38.46
- Support Level
- SNTI $1.92
- TLYS $1.66
- Resistance Level
- SNTI $2.29
- TLYS $1.55
- Average True Range (ATR)
- SNTI 0.16
- TLYS 0.10
- MACD
- SNTI -0.03
- TLYS -0.01
- Stochastic Oscillator
- SNTI 0.00
- TLYS 3.51
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About TLYS Tilly's Inc.
Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.